XML 52 R43.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity - January 2016 Financing (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 26, 2017
Mar. 31, 2016
Jan. 31, 2016
Sep. 30, 2016
Mar. 31, 2016
Sep. 30, 2017
Dec. 31, 2016
Feb. 28, 2015
Stockholders Equity Note [Line Items]                
Aggregate offering price     $ 10,000          
Aggregate gross proceeds from sale of common stock and warrants   $ 7,800 2,200          
Payments of transaction costs       $ 400        
Net proceeds from sale of common stock and warrants after transaction costs         $ 9,600      
Warrant liabilities           $ 636 $ 846  
Outstanding warrants | Significant Unobservable Inputs (Level 3)                
Stockholders Equity Note [Line Items]                
Fair value of warrants issued during the period     $ 4,800          
Dividend yield (as a percent)           0.00% 0.00%  
Common Stock                
Stockholders Equity Note [Line Items]                
Maximum number of warrants to be purchased (in shares)     568,184          
Exercise price (in usd per share)     $ 8.80         $ 18.20
Number of securities called by each warrant (in shares)     0.5          
Warrants issued (in shares)     126,421          
Payments of transaction costs   $ 200            
Expected term 5 years 23 days 7 years            
Volatility rate (as a percent) 88.30% 99.40% 101.90%          
Dividend yield (as a percent)   0.00%            
Risk-free interest rate (as a percent)   1.40% 1.60%          
Common Stock | Outstanding warrants | Significant Unobservable Inputs (Level 3)                
Stockholders Equity Note [Line Items]                
Liabilities, Fair Value Adjustment             $ 700  
Common Stock                
Stockholders Equity Note [Line Items]                
Common stock, maximum number of shares to be purchased (in shares)     1,136,364          
Issuance of common stock (in shares)     252,842